Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Fitzal

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer, , , et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2012
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
International Journal of Surgery (London, England)|June 6, 2022
The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center studyMichael Bolliger, Pia Lanmüller, Michael Schuetz, et al.
Breast (Edinburgh, Scotland)|July 15, 2014
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patientsAnna S Berghoff, Rupert Bartsch, Matthias Preusser, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2014
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapyMathilde Foedermayr, Miriam Sebesta, Margaretha Rudas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy OnlyMartin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Breast Care (Basel, Switzerland)|December 17, 2010
Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect RatioPeter Blaha, Ruth Exner, Andrea Dal Borgo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain MetastasesElisabeth S Bergen, Anna S Berghoff, Mela Medjedovic, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 14, 2021
Androgen Receptor is Expressed in Breast Cancer Brain MetastasesElisabeth S Bergen, Anna S Berghoff, Ariane Steindl, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer, , , et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2012
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
International Journal of Surgery (London, England)|June 6, 2022
The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center studyMichael Bolliger, Pia Lanmüller, Michael Schuetz, et al.
Breast (Edinburgh, Scotland)|July 15, 2014
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patientsAnna S Berghoff, Rupert Bartsch, Matthias Preusser, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2014
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapyMathilde Foedermayr, Miriam Sebesta, Margaretha Rudas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy OnlyMartin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Breast Care (Basel, Switzerland)|December 17, 2010
Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect RatioPeter Blaha, Ruth Exner, Andrea Dal Borgo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain MetastasesElisabeth S Bergen, Anna S Berghoff, Mela Medjedovic, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 14, 2021
Androgen Receptor is Expressed in Breast Cancer Brain MetastasesElisabeth S Bergen, Anna S Berghoff, Ariane Steindl, et al.
Pageof 9